SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 extension data for investigational Duchenne therapy deramiocel, presented at the World Muscle Society congress, showed slower upper-limb decline among patients who switched from placebo, drawing attention to the stock. Traders largely view the findings as supportive ahead of the FDAs November review, while debate continues over the datas statistical interpretation and whether it will change the agencys decision.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera is drawing attention after positive Phase 2 results for ABCL635, its investigational menopause treatment, with traders focused on a fuller data presentation and the drugs potential path toward Phase 3. The community is largely bullish on the clinical and platform prospects, while some caution that efficacy and safety still need validation in larger trials; JPMorgans Overweight coverage has added to the discussion.

Goodyear Tire & Rubber Co. engages in the development, manufacture, distribution, and sale of tires. It operates through the following geographical segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The Americas segment is involved in the development, manufacture, distribution, and sale of tires and related products and services in North, Central, and South America. The Europe, Middle East, and Africa segment focuses on the development, manufacture, distribution, and sale of tires for automobiles, trucks, buses, aircraft, motorcycles, earthmoving, mining, and industrial equipment throughout Europe, the Middle East, and Africa. The Asia Pacific segment refers to the development, manufacture, distribution, and sales of tires for automobiles, trucks, buses, aircraft, farm, earthmoving, mining, and industrial equipment throughout the Asia Pacific region. The company was founded by Frank A. Seiberling on August 29, 1898 and is headquartered in Akron, OH.

Goodyear Tire & Rubber Co.

Goodyear is drawing attention amid a steep, volatile decline and debate over its depressed valuation and heavy debt. Bulls speculate about a takeover or short squeeze, while bears point to financial risk and pressure from oil and input costs; no buyout is confirmed.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFis prolonged share-price decline is driving a frustrated, sharply divided discussion, with traders blaming past share offerings and insider sales, rising-rate concerns, and perceived short pressure. Bulls point to business growth and recent product developments, but many say those positives have not translated into stronger stock performance; others expect further downside ahead of Q3 earnings.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance shares surged after the company raised its revenue outlook on stronger demand for Amtagvi and Proleukin, prompting analyst upgrades and optimism about its commercial growth. Traders also cite possible short covering and upcoming lung-cancer data, while others warn the sharp rally may be overextended and raise concerns about potential dilution.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention amid a sharp oil selloff and volatile, conflicting Iran-war headlines: traders point to increased Gulf exports, Saudi pipeline rerouting and the planned Strategic Petroleum Reserve loan as easing supply concerns. Others argue that stalled diplomacy and continued risks to shipping and fuel supplies could keep oil elevated, leaving bulls and bears debating whether the drop marks a lasting unwind or a temporary dip.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCNs sharp rally and perceived technical breakout are driving bullish chatter, with traders eyeing further momentum while others warn the move could fade. Some attribute the excitement to broader altcoin strength and Zebecs payroll and payments utility; talk of Robinhood or BlackRock involvement remains speculative.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is drawing attention as its shares and the broader defense sector sell off despite elevated missile demand and a large backlog. Traders debate whether the weakness reflects sector rotation and budget or political concerns, while bullish voices point to replenishment needs and new defense contracts; the reasons for the decline remain disputed.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

Golds pullback is drawing attention as rising Treasury yields, a stronger dollar, and hawkish Fed expectations weigh on precious metals. Traders are split between buying the dip and waiting for a clearer bottom, while others expect further weakness if yields stay elevated.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is drawing attention as traders track a possible renewed breakout in the Magnificent Seven and its role in leading or supporting the broader market. Bulls point to mega-cap strength and rotation back toward the group, while skeptics cite narrow market breadth and doubts about AI spending returns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
